Prof. Chan Chung Ngor Juliana

Professor of Medicine and Therapeutics Director, Hong Kong Institute of Diabetes and Obesity Strategic Advisor, CU Phase 1 Clinical Trial Centre  Director, Clinical Research Management Office Specialty Clinical Pharmacology, Endocrinology and Diabetes   Areas of research Novel drugs in diabetes and its complications Epidemiology, genetics, precision medicine, care models

Involvement in sponsored studies including early phase and landmark studies

• Serve as PIs, national coordinator and steering committee members of over 100 clinical trials in diabetes and cardio-renal complications since 1995, examples include:
  RENAAL, ACE, EXSCEL, TECOS, EASIE, EXSCEL, FIDELIO, ARISE using renin angiotensin system blockers, alpha glucosidase inhibitors, insulin, glucagon like peptide 1, Dipeptidyl peptidase 4 inhibitor, glucose kinase activator, non-steroidal mineralocorticoid antagonist, aldose reductase inhibitors
  Continuous Glucose Monitoring System

• Early phase and mechanistic studies including glucose and insulin clamp studies 

 

Hyperlink to personal webpage in host dept and other institutes 

• https://www.mect.cuhk.edu.hk/people/julianachan.html
• http://www.hkido.cuhk.edu.hk/